Celestica Announces First Quarter 2024 Financial Results
GlobeNewswire
*Q1 2024 revenue and non-IFRS adjusted EPS* above the high end of guidance ranges;
**2024 full-year outlook raised*(All..
*Q1 2024 revenue and non-IFRS adjusted EPS* above the high end of guidance ranges;
**2024 full-year outlook raised*(All..
· Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands..
NEENAH, WI, April 24, 2024 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second..